
Jinfeng laboratory’s announcement on the review results of the (phase i) laboratory animal center joint operation agency
jinfeng laboratory’s announcement on the review results of the (phase i) laboratory animal center joint operation agency
according to jinfeng laboratory's "notice on convening the review meeting of joint operation institutions of jinfeng laboratory (phase i) experimental animal center", experts have been organized to conduct a public review of participating institutions on august 18, 2022. the review results are shown in the table below :
serial number |
participating institutions |
overall rating |
ranking |
1 |
chengdu dashuo experimental animal co., ltd. |
74.60 |
1 |
2 |
sichuan sharpaisen pharmaceutical technology co., ltd. |
33.80 |
2 |
3 |
chengdu yinchuangyuan pharmaceutical technology co., ltd. |
30.60 |
3 |
if any unit or individual has any objection to the publicity content, please submit it in writing to jinfeng laboratory within the publicity period. overdue application will not be accepted. opinions should be based on facts and provide necessary supporting documents. if opinions are expressed in the name of the unit, the official seal of the unit should be affixed; if opinions are expressed in the name of an individual, the real name should be signed and a contact number should be left for verification.
public announcement time: september 14-september 18, 2022
contact person: teacher xiao
contact information: 023-68059917
acceptance address: jinfeng laboratory (no. 313 gaoteng avenue, jiulongpo district, chongqing)
jinfeng laboratory
september 14, 2022
- About Us
-
Research Platform
- Major Disease Sample Database
- Innovative Drug Verification And Transformation Platform
- Experimental Animal Center
- Life And Health Future Laboratory
- Biomedical Imaging Platform
- Cell Multi-Omics Platform
- Pathology Technology Platform
- Bioinformatics Research And Application Center
- Jinfeng Pathology Precision Diagnosis Center
- Research Team
- Information Center
- Join Us